These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8727012)

  • 1. Commentary on the present state of knowledge for myoblast transfer therapy.
    Grounds MD
    Cell Transplant; 1996; 5(3):431-3. PubMed ID: 8727012
    [No Abstract]   [Full Text] [Related]  

  • 2. A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts.
    Fan Y; Beilharz MW; Grounds MD
    Cell Transplant; 1996; 5(3):421-9. PubMed ID: 8727011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human gene therapy with myoblast transfer.
    Law PK; Goodwin TG; Fang Q; Quinley T; Vastagh G; Hall T; Jackson T; Deering MB; Duggirala V; Larkin C; Florendo JA; Li LM; Yoo TJ; Chase N; Neel M; Krahn T; Holcomb RL
    Transplant Proc; 1997 Jun; 29(4):2234-7. PubMed ID: 9193606
    [No Abstract]   [Full Text] [Related]  

  • 4. Myoblast transfer in muscular dystrophy: panacea or pie in the sky?
    Dubowitz V
    Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179
    [No Abstract]   [Full Text] [Related]  

  • 5. Losartan enhances the success of myoblast transplantation.
    Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
    Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
    Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
    Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle.
    Gibson AJ; Karasinski J; Relvas J; Moss J; Sherratt TG; Strong PN; Watt DJ
    J Cell Sci; 1995 Jan; 108 ( Pt 1)():207-14. PubMed ID: 7738097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental challenge for the treatment of Duchenne muscular dystrophy using a vascularized free muscle graft.
    Dohi D; Ikuta Y; Ishida O; Kimori K; Kuroki H
    Microsurgery; 1994; 15(12):871-6. PubMed ID: 7707929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.
    Vilquin JT; Wagner E; Kinoshita I; Roy R; Tremblay JP
    J Cell Biol; 1995 Nov; 131(4):975-88. PubMed ID: 7490298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
    Brussee V; Merly F; Tardif F; Tremblay JP
    Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral-mediated gene transfer into murine and human skeletal muscle for the correction of dystrophin deficiency.
    Fassati A; Serpente P; Wells DJ; Walsh FS; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):275S. PubMed ID: 8736933
    [No Abstract]   [Full Text] [Related]  

  • 12. Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?
    Ferrari G; Mavilio F
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S7-10. PubMed ID: 12206789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.
    Miller RG; Sharma KR; Pavlath GK; Gussoni E; Mynhier M; Lanctot AM; Greco CM; Steinman L; Blau HM
    Muscle Nerve; 1997 Apr; 20(4):469-78. PubMed ID: 9121505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.
    Torrente Y; Tremblay JP; Pisati F; Belicchi M; Rossi B; Sironi M; Fortunato F; El Fahime M; D'Angelo MG; Caron NJ; Constantin G; Paulin D; Scarlato G; Bresolin N
    J Cell Biol; 2001 Jan; 152(2):335-48. PubMed ID: 11266450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
    Moisset PA; Gagnon Y; Karpati G; Tremblay JP
    Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor.
    Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Höger H
    Neuropediatrics; 1994 Aug; 25(4):176-82. PubMed ID: 7824089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
    Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
    Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene.
    Dunckley MG; Eperon IC; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):276S. PubMed ID: 8736934
    [No Abstract]   [Full Text] [Related]  

  • 20. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.